The Cooper Companies found using ticker (COO) have now 11 analysts in total covering the stock. The consensus rating is ‘Buy’. The target price ranges between 560 and 335 with the average target price sitting at 421. Given that the stocks previous close was at 323.49 this would indicate that there is a potential upside of 30.1%. The 50 day moving average now sits at 345.46 and the 200 day MA is 392.78. The company has a market capitalisation of $15,890m. Company Website: https://www.coopercos.com
The potential market cap would be $20,679m based on the market concensus.
The Cooper Companies, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women’s health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies was founded in 1958 and is headquartered in San Ramon, California.
